| Variables | All (n = 45) |
| Type, n (%) |
|
| HD | 6 (13.3) |
| HDF | 22 (48.9) |
| HD/HDF | 17 (37.8) |
| Dialysis duration, mo | 34.3 ± 10.8 |
| Vascular access, n (%) |
|
| Catheter | 28 (62.2) |
| AVF | 17 (37.8) |
| KT/V | 1.2 ± 0.2 |
| IDWG, Kg | 1.9 ± 0.4 |
| RD, mL/day | 338.8 ± 36.6 |
| >500 | 6 (20.7) |
| 200 - 400 | 12 (41.4) |
| <200 | 11 (37.9) |
| EPO, n (%) | 45 (100) |
| EPO dosing, IU/Kg/week | 11,187.8 ± 2450.5 |
| IV iron therapy, n (%) | 41 (91.1) |
| IV Iron dosing, mg/week | 130.6 ± 46.7 |
| Financial support, n (%) |
|
| Patient/family | 8 (17.8) |
| Private and public entreprises | 35 (77.8) |
| Government | 2 (4.4) |